Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

28.90
-0.2600-0.89%
Post-market: 28.70-0.2000-0.69%16:53 EST
Volume:2.10M
Turnover:60.16M
Market Cap:17.80B
PE:12.44
High:29.02
Open:28.29
Low:28.06
Close:29.16
52wk High:35.43
52wk Low:17.24
Shares:616.00M
Float Shares:608.00M
Volume Ratio:1.05
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.32
EPS(LYR):1.54
ROE:16.58%
ROA:7.78%
PB:3.04
PE(LYR):18.80

Loading ...

Genmab A/S Stock Falls Thursday, Underperforms Market

Dow Jones
·
5 hours ago

Genmab Expands Oncology Pipeline With New First-in-Human GEN1079 Trial

TIPRANKS
·
6 hours ago

Genmab Shares Fall as Costs Weigh on Earnings -- Market Talk

Dow Jones
·
Yesterday

Genmab price target raised to $40 from $39 at H.C. Wainwright

TIPRANKS
·
Feb 18

Genmab Q4 EPS $0.05 Misses $0.44 Estimate, Sales $1.058B Miss $4.401B Estimate

Benzinga
·
Feb 18

Genmab 2025 Net Profit Falls, Revenue Increases; 2026 Revenue Outlook Issued

MT Newswires Live
·
Feb 18

GUIDANCE: (GMAB) Genmab Expects 2026 Revenue Range $4.07B - $4.40B, vs. FactSet Est of $4.32B

MT Newswires Live
·
Feb 18

Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B

TIPRANKS
·
Feb 18

Genmab Price Target Announced at $41.50/Share by Jefferies

Dow Jones
·
Feb 17

Genmab resumed with a Buy at Jefferies

TIPRANKS
·
Feb 17

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Feb 17

Genmab Price Target Announced at $34.00/Share by Morgan Stanley

Dow Jones
·
Feb 16

Genmab A/S Stock Flat Thursday, Outperforms Market

Dow Jones
·
Feb 13

Earning Preview: Genmab A/S Q4 revenue is expected to increase by 16.55%, and institutional views are predominantly bullish

Earnings Agent
·
Feb 10

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Feb 10

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Feb 05

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Feb 03

Genmab A/S Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jan 30

Genmab Price Target Maintained With a $39.00/Share by HC Wainwright & Co.

Dow Jones
·
Jan 28

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Genmab (GMAB)

TIPRANKS
·
Jan 28